ProQR Therapeutics N.V. Interest Expense On Lease Liabilities
ProQR Therapeutics N.V. (PRQR) reported Interest Expense On Lease Liabilities of EUR 612.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-12.
Financial Statements › Expense Statement › Interest Expense
ifrs-full:InterestExpenseOnLeaseLiabilities · last filed 2026-03-12
| Period end | Interest Expense On Lease Liabilities 12 month | Interest Expense On Lease Liabilities 12 month as first filed |
|---|---|---|
| 2025-12-31 | 612.00K EUR 20-F · filed 2026-03-12 | |
| 2024-12-31 | 713.00K EUR 20-F · filed 2026-03-12 | |
| 2023-12-31 | 774.00K EUR 20-F · filed 2026-03-12 | |
| 2022-12-31 | 793.00K EUR 20-F · filed 2025-03-13 | |
| 2021-12-31 | 835.00K EUR 20-F · filed 2024-03-13 | |
| 2020-12-31 | 409.00K EUR 20-F · filed 2023-03-29 | |
| 2019-12-31 | 73.00K EUR 20-F · filed 2022-04-29 | 48.00K EUR 20-F · filed 2020-03-31 |